Clinic
Methodist Health Centers
Methodist Health Centers was paid $8.64M by Medicaid between Nov 2020 and Nov 2024, across 92 billing codes. Its largest line is 99284, emergency room visit (serious) — 76% of everything it billed.
33Billing provider infoMETHODIST HEALTH CENTERS
SUGAR LAND, TX 77479
SUGAR LAND, TX 77479
33aNPI1497871628assigned 03/21/2007
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$8.64M
24GClaims97,005
24DCodes billed92
24AFirst – last monthNov 2020 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#49 of 320
Median peer was paid$205K
This provider vs. median42×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 86 | $10K | |
| 2021 | 24,002 | $1.20M | |
| 2022 | 31,155 | $3.02M | |
| 2023 | 27,512 | $3.88M | |
| 2024incomplete | 14,250 | $540K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 76% | 6,596 | 6,255 | $6.57M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.2% | 6,644 | 6,315 | $792K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.8% | 1,865 | 1,699 | $504K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 1,607 | 1,530 | $159K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,191 | 1,914 | $86K |
| 80053 | Comprehensive metabolic panel | <1% | 10,297 | 8,381 | $66K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 416 | 399 | $56K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 2,169 | 2,099 | $56K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,965 | 3,755 | $45K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,449 | 8,414 | $40K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,313 | 2,079 | $32K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 772 | 747 | $29K |
80 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,433 | $28K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,168 | $19K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 188 | $15K |
| 83880 | <1% | 1,526 | $12K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 900 | $12K |
| 84703 | <1% | 1,685 | $9K | |
| 84484 | <1% | 3,217 | $8K | |
| G0378 | Hospital observation service, per hour | <1% | 199 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 680 | $6K |
| 81001 | <1% | 3,336 | $6K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,092 | $6K |
| 87088 | <1% | 1,401 | $6K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 190 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 254 | $5K |
| 83605 | <1% | 1,422 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 106 | $3K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,229 | $3K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,867 | $3K |
| 83690 | <1% | 1,351 | $3K | |
| 83735 | <1% | 1,699 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 636 | $3K |
| 86850 | <1% | 709 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,008 | $3K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,466 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 31 | $2K |
| 76801 | <1% | 26 | $2K | |
| 87400 | <1% | 102 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,615 | $1K |
| 85610 | <1% | 1,655 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 979 | $1K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,105 | $1K |
| 97161 | <1% | 105 | $1K | |
| 85730 | <1% | 1,080 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,050 | $996.25 |
| 86901 | <1% | 1,121 | $752.49 | |
| 84100 | <1% | 775 | $744.32 | |
| 87077 | <1% | 230 | $705.43 | |
| 80061 | Lipid panel | <1% | 425 | $701.01 |
| 87040 | <1% | 274 | $640.44 | |
| CP008 | <1% | 14 | $614.93 | |
| 85027 | <1% | 309 | $603.93 | |
| CP007 | <1% | 16 | $555.83 | |
| 84702 | <1% | 60 | $498.27 | |
| 81003 | <1% | 179 | $494.28 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 20 | $481.94 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 279 | $400.15 |
| 86900 | <1% | 914 | $376.16 | |
| 87186 | <1% | 177 | $375.40 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 25 | $308.16 |
| 82550 | <1% | 168 | $299.52 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 41 | $296.73 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 685 | $287.44 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 18 | $275.16 |
| 87070 | <1% | 56 | $261.79 | |
| 86769 | <1% | 31 | $258.68 | |
| 86413 | <1% | 26 | $257.36 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 75 | $254.13 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 117 | $240.92 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 85 | $187.14 |
| 84439 | <1% | 68 | $163.21 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 49 | $140.91 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 225 | $90.40 |
| 85007 | <1% | 65 | $67.12 | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 198 | $52.30 |
| 85379 | <1% | 12 | $49.76 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 70 | $46.01 |
| 82150 | <1% | 18 | $28.28 | |
| 83615 | <1% | 14 | $23.11 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 59 | $15.51 |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,534 | $7.42 |
| J2704 | Injection, propofol, 10 mg | <1% | 599 | $6.66 |
| J3490 | Unclassified drugs | <1% | 12 | $6.28 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 13 | $0.00 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 14 | $0.00 |
| 85014 | 0% | 14 | $0.00 | |
| C1769 | Guide wire | 0% | 40 | $0.00 |
| 96376 | 0% | 36 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 14 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIEBENALER, CHRISTOPHER (CEO)